Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.

Chen JJ, Dashtipour K.

Pharmacotherapy. 2013 Mar;33(3):304-18. doi: 10.1002/phar.1196. Epub 2013 Feb 11. Review.

PMID:
23400888
2.

Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.

Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J.

Toxicon. 2013 Jun 1;67:94-114. doi: 10.1016/j.toxicon.2012.12.004. Epub 2013 Feb 4. Review.

PMID:
23380701
3.

Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions.

Chancellor MB, Elovic E, Esquenazi A, Naumann M, Segal KR, Schiavo G, Smith CP, Ward AB.

Toxicon. 2013 Jun 1;67:129-40. doi: 10.1016/j.toxicon.2013.01.020. Epub 2013 Feb 13. Review.

PMID:
23415704
4.

Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.

Naumann M, Dressler D, Hallett M, Jankovic J, Schiavo G, Segal KR, Truong D.

Toxicon. 2013 Jun 1;67:141-52. doi: 10.1016/j.toxicon.2012.10.020. Epub 2012 Nov 23. Review.

PMID:
23178324
5.

Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome.

Esquenazi A, Albanese A, Chancellor MB, Elovic E, Segal KR, Simpson DM, Smith CP, Ward AB.

Toxicon. 2013 Jun 1;67:115-28. doi: 10.1016/j.toxicon.2012.11.025. Epub 2012 Dec 5. Review.

PMID:
23220492
6.

Clinical differences between botulinum neurotoxin type A and B.

Bentivoglio AR, Del Grande A, Petracca M, Ialongo T, Ricciardi L.

Toxicon. 2015 Dec 1;107(Pt A):77-84. doi: 10.1016/j.toxicon.2015.08.001. Epub 2015 Aug 7. Review.

PMID:
26260691
7.
8.

Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.

Lakraj AA, Moghimi N, Jabbari B.

Toxins (Basel). 2013 Apr 23;5(4):821-40. doi: 10.3390/toxins5040821. Review.

9.

Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact.

Jandhyala R.

J Plast Reconstr Aesthet Surg. 2012 Jun;65(6):720-31. doi: 10.1016/j.bjps.2011.12.001. Epub 2012 Jan 4.

PMID:
22225675
10.

The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.

Wortzman MS, Pickett A.

Aesthet Surg J. 2009 Nov;29(6 Suppl):S34-42. doi: 10.1016/j.asj.2009.09.014. Review.

PMID:
19945003
11.

Botulinum Toxin: Preparations for Clinical Use, Immunogenicity, Side Effects, and Safety Profile.

Dashtipour K, Pedouim F.

Semin Neurol. 2016 Feb;36(1):29-33. doi: 10.1055/s-0035-1571213. Epub 2016 Feb 11. Review.

PMID:
26866493
12.

Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice.

Scaglione F.

Toxins (Basel). 2016 Mar 4;8(3). pii: E65. doi: 10.3390/toxins8030065. Review.

13.

A pharmacodynamic comparison study of different botulinum toxin type A preparations.

Kim SB, Ban B, Jung KS, Yang GH.

Dermatol Surg. 2013 Jan;39(1 Pt 2):150-4. doi: 10.1111/dsu.12070.

PMID:
23301818
14.

[Use of botulinum neurotoxin therapy].

Mukai Y, Kaji R.

Brain Nerve. 2011 Jul;63(7):775-84. Review. Japanese.

PMID:
21747148
15.

The evolution of botulinum neurotoxin type A for cosmetic applications.

Carruthers J, Carruthers A.

J Cosmet Laser Ther. 2007 Sep;9(3):186-92. Review.

PMID:
17763029
16.

Unlabeled uses of botulinum toxins: a review, part 1.

Cheng CM, Chen JS, Patel RP.

Am J Health Syst Pharm. 2006 Jan 15;63(2):145-52. Review.

PMID:
16390928
17.

Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.

Glogau RG.

Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S191-7. Review.

PMID:
12569968
18.

Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.

Matarasso A, Shafer D.

Aesthet Surg J. 2009 Nov;29(6 Suppl):S72-9. doi: 10.1016/j.asj.2009.09.016.

PMID:
19945008
19.

Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.

Chapman MA, Barron R, Tanis DC, Gill CE, Charles PD.

Clin Ther. 2007 Jul;29(7):1325-37. Review.

PMID:
17825685
20.

Comparisons among botulinum toxins: an evidence-based review.

Klein AW, Carruthers A, Fagien S, Lowe NJ.

Plast Reconstr Surg. 2008 Jun;121(6):413e-422e. doi: 10.1097/PRS.0b013e318170813c. Review.

PMID:
18520868

Supplemental Content

Support Center